Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Dr. Marco DeLuca

Department of Clinical Trials, Aurora Institute of Health Sciences, Aurora University, Bellavista, Italy
Publications

Ensuring Drug Interchangeability: Key Bioequivalence Principles

Bioequivalence studies are critical for demonstrating drug product interchangeability by assessing pharmacokinetic equivalence. Regulatory agencies provide stringent guidelines, often utilizing dissolution testing and statistical analysis. Advances include novel statistical methods and in vitro data. The Biopharmaceutics Classification System (BCS)... Read More»

Dr. Marco DeLuca

: Clin Pharmacol Biopharm 14: 567.

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article

Top Connection closed successfully.